XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Common Stock
Additional paid-in capital
Cumulative Effect, Period of Adoption, Adjustment
Additional paid-in capital
Accumulated deficit
Cumulative Effect, Period of Adoption, Adjustment
Accumulated deficit
Cumulative Effect, Period of Adoption, Adjustment
Total
Balance at Dec. 31, 2020 $ 161   $ 1,528,535   $ (1,466,056)   $ 62,640
Balance (in shares) at Dec. 31, 2020 160,616,675            
Increase (Decrease) in Stockholders' Equity (Deficit)              
Issuance of common stock related to share-based awards and employee stock purchase plan $ 1   2,229       2,230
Issuance of common stock related to share-based awards and employee stock purchase plan (in shares) 1,314,337            
Share-based compensation expense related to share-based awards and employee stock purchase plan     5,396       5,396
Net income         39,926   39,926
Balance at Mar. 31, 2021 $ 162   1,536,160   (1,426,130)   110,192
Balance (in shares) at Mar. 31, 2021 161,931,012            
Balance at Dec. 31, 2020 $ 161   1,528,535   (1,466,056)   62,640
Balance (in shares) at Dec. 31, 2020 160,616,675            
Increase (Decrease) in Stockholders' Equity (Deficit)              
Net income             487,074
Balance at Sep. 30, 2021 $ 163   1,558,760   (978,982)   579,941
Balance (in shares) at Sep. 30, 2021 163,405,013            
Balance at Mar. 31, 2021 $ 162   1,536,160   (1,426,130)   110,192
Balance (in shares) at Mar. 31, 2021 161,931,012            
Increase (Decrease) in Stockholders' Equity (Deficit)              
Issuance of common stock related to share-based awards and employee stock purchase plan $ 1   5,671       5,672
Issuance of common stock related to share-based awards and employee stock purchase plan (in shares) 900,941            
Share-based compensation expense related to share-based awards and employee stock purchase plan     4,589       4,589
Net income         391,303   391,303
Balance at Jun. 30, 2021 $ 163   1,546,420   (1,034,827)   511,756
Balance (in shares) at Jun. 30, 2021 162,831,953            
Increase (Decrease) in Stockholders' Equity (Deficit)              
Issuance of common stock related to share-based awards and employee stock purchase plan     6,134       6,134
Issuance of common stock related to share-based awards and employee stock purchase plan (in shares) 573,060            
Share-based compensation expense related to share-based awards and employee stock purchase plan     6,206       6,206
Net income         55,845   55,845
Balance at Sep. 30, 2021 $ 163   1,558,760   (978,982)   579,941
Balance (in shares) at Sep. 30, 2021 163,405,013            
Balance at Dec. 31, 2021 $ 162 $ (110,217) 1,543,357 $ 66,167 (937,608) $ (44,050) $ 605,911
Balance (in shares) at Dec. 31, 2021 162,036,461           162,036,461
Increase (Decrease) in Stockholders' Equity (Deficit)              
Issuance of common stock related to share-based awards and employee stock purchase plan $ 1   1,520       $ 1,521
Issuance of common stock related to share-based awards and employee stock purchase plan (in shares) 1,087,966            
Share-based compensation expense related to share-based awards and employee stock purchase plan     6,089       6,089
Repurchases of common stock $ (8)   (90,481)       (90,489)
Repurchases of common stock (in shares) (8,009,272)            
Net income         38,801   38,801
Balance at Mar. 31, 2022 $ 155   1,350,268   (832,640)   517,783
Balance (in shares) at Mar. 31, 2022 155,115,155            
Balance at Dec. 31, 2021 $ 162 $ (110,217) 1,543,357 $ 66,167 (937,608) $ (44,050) $ 605,911
Balance (in shares) at Dec. 31, 2021 162,036,461           162,036,461
Increase (Decrease) in Stockholders' Equity (Deficit)              
Repurchases of common stock             $ (123,400)
Repurchases of common stock (in shares)             (10,800,000)
Net income             $ 126,198
Balance at Sep. 30, 2022 $ 153   1,336,153   (745,243)   $ 591,063
Balance (in shares) at Sep. 30, 2022 153,319,417           153,319,417
Balance at Mar. 31, 2022 $ 155   1,350,268   (832,640)   $ 517,783
Balance (in shares) at Mar. 31, 2022 155,115,155            
Increase (Decrease) in Stockholders' Equity (Deficit)              
Issuance of common stock related to share-based awards and employee stock purchase plan $ 1   4,314       4,315
Issuance of common stock related to share-based awards and employee stock purchase plan (in shares) 818,235            
Share-based compensation expense related to share-based awards and employee stock purchase plan     6,601       6,601
Repurchases of common stock $ (3)   (32,893)       (32,896)
Repurchases of common stock (in shares) (2,757,081)            
Net income         37,080   37,080
Balance at Jun. 30, 2022 $ 153   1,328,290   (795,560)   532,883
Balance (in shares) at Jun. 30, 2022 153,176,309            
Increase (Decrease) in Stockholders' Equity (Deficit)              
Issuance of common stock related to share-based awards and employee stock purchase plan     796       796
Issuance of common stock related to share-based awards and employee stock purchase plan (in shares) 143,108            
Share-based compensation expense related to share-based awards and employee stock purchase plan     7,067       7,067
Net income         50,317   50,317
Balance at Sep. 30, 2022 $ 153   $ 1,336,153   $ (745,243)   $ 591,063
Balance (in shares) at Sep. 30, 2022 153,319,417           153,319,417